dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Owonikoko, Taofeek |
dc.contributor.author | Park, Keunchil |
dc.contributor.author | Govindan, Ramaswamy |
dc.contributor.author | Ready, Neal |
dc.contributor.author | Reck, M. |
dc.contributor.author | Peters, S. |
dc.contributor.author | Navarro Mendivil, Alejandro |
dc.date.accessioned | 2022-06-29T09:31:53Z |
dc.date.available | 2022-06-29T09:31:53Z |
dc.date.issued | 2021-04-20 |
dc.identifier.citation | Owonikoko TK, Park K, Govindan R, Ready N, Reck M, Peters S, et al. Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451. J Clin Oncol. 2021 Apr 20;39(12):1349–59. |
dc.identifier.issn | 1527-7755 |
dc.identifier.uri | https://hdl.handle.net/11351/7760 |
dc.description | Nivolumab; Teràpia de manteniment; Càncer de pulmó de cèl·lules petites |
dc.language.iso | eng |
dc.publisher | Lippincott Williams & Wilkins |
dc.relation.ispartofseries | Journal of clinical oncology;39(12) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Quimioteràpia combinada |
dc.subject.mesh | Small Cell Lung Carcinoma |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.title | Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451 |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1200/JCO.20.02212 |
dc.subject.decs | carcinoma pulmonar de células pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | http://dx.doi.org/10.1200/JCO.20.02212 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Owonikoko TK] Winship Cancer Institute of Emory University, Atlanta, GA. [Park K] Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. [Govindan R] Alvin J Siteman Cancer Center at Washington University School of Medicine, St Louis, MO. [Ready N] Duke University Medical Center, Durham, NC. [Reck M] Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany. [Peters S] Oncology Department, Lausanne University Hospital, Lausanne, Switzerland. [Navarro A] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 33683919 |
dc.identifier.wos | 000657448400005 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |